Centessa Pharmaceuticals Plc (CNTA)
39.54
-0.01
(-0.03%)
USD |
NASDAQ |
Apr 08, 16:00
39.54
0.00 (0.00%)
After-Hours: 16:31
Centessa Pharmaceuticals Shareholders Equity (Quarterly) : 526.86M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.26B |
| Eli Lilly & Co. | 26.54B |
| Apellis Pharmaceuticals, Inc. | 370.15M |
| Silence Therapeutics Plc | 62.30M |
| Adaptimmune Therapeutics Plc | -70.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 690.20M |
| Total Liabilities (Quarterly) | 163.34M |
| Debt to Equity Ratio | 0.2247 |
| Current Ratio | 8.568 |
| Net Debt Paydown Yield | -0.18% |